Table 4 2013 Pricing comparison of SEB Epoetins in five European countries [44]
From: Potential impact of subsequent entry biologics in nephrology practice in Canada
| Â | Germany | UK | France | Italy | Spain |
|---|---|---|---|---|---|
Number of SEB epoetins on market | 4 | 2 | 2 | 3 | 2 |
Price innovator vs SEB (€/ddd)* | 6.06 vs. 6.02 | 5.65 vs. 5.20 | 6.65 vs. 5.72 | 10.47 vs 8.91 | 8.65 vs. 6.06 |
Average price difference between innovator epoetin and SEB (%) | 1 | 8 | 14 | 15 | 30 |